ArticleClinical parkinsonism & related disorders2025

Effects of the continuous subcutaneous infusion of foslevodopa-foscarbidopa on swallowing in patients with Parkinson's disease.

Makito Hirano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.